Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents early in the 2024 to 2025 season, according to research published in the Nov. 21 ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

FluMist, a self-administered flu vaccine, is approved for ages 2-49, but will be available in the 2025-2026 season. RSV vaccination is vital for older adults, with new guidelines for those aged 60-74, ...

The goal is to "create a vaccine that prevents the most severe disease manifestations that result in hospitalization or death ...

Some hospitals in the U.S. are seeing an increase in cases of RSV and so-called "walking pneumonia." Here's what you need to ...

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe ...

The NHS says the RSV vaccine is recommended from 28 weeks of pregnancy, to protect the baby for the first few months after ...